<html>
<head>PUBMED IDs for CAC-1</head>
<body bgcolor='#C5F0F2'><h1>CAC-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9500206/'>Cloning and characterization of a cDNA fragment coding beta-casein-like protein preferentially expressed in cervical adenocarcinoma cell line CAC-1.</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9887247/'>CA 125 is dominantly expressed by arrest of G0/G1 phase in uterine cervical adenocarcinoma cell line.</a> January 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/9887237/'>PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.</a> January 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/9887230/'>p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.</a> January 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/15202000/'>Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells.</a> June 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16682952/'>MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.</a> May 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/23504048/'>Low-dose SN-38 with paclitaxel induces lethality in human uterine cervical adenocarcinoma cells by increasing caspase activity.</a> December 15  2013<br></body></html>
